Fulgent Genetics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Fulgent Genetics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2017 to Q4 2023.
  • Fulgent Genetics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $15.9M, a 461% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $15.9M +$13.1M +461% Dec 31, 2023 10-K 2024-02-28
Q4 2022 $2.83M +$223K +8.55% Dec 31, 2022 10-K 2024-02-28
Q4 2021 $2.61M +$588K +29.1% Dec 31, 2021 10-K 2023-02-28
Q4 2020 $2.02M -$104K -4.89% Dec 31, 2020 10-K 2022-02-28
Q4 2019 $2.13M +$677K +46.8% Dec 31, 2019 10-K 2022-02-28
Q4 2018 $1.45M +$1.33M +1127% Dec 31, 2018 10-K 2020-03-13
Q4 2017 $118K Dec 31, 2017 10-K 2019-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.